CURDESIL
Live / Registered — Registered (as of 23 Jan 2024)
What this means for you
Registered since 23 Jan 2024. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 90895002
- Registration number
- 7282824
- Mark type
- Word mark
- Filed
- 20 Aug 2021
- Published for opposition
- 07 Mar 2023
- Registered
- 23 Jan 2024
- Attorney of record
- Robert J. Kenney
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations for the treatment of cancer, inflammation, blood diseases, asthma, skin disease and hypercholesterolemia; vaccines; biochemical medicines for the treatment of cancer, inflammation, blood diseases, asthma, skin disease and hypercholesterolemia; chemico-pharmaceutical preparations for the treatment of cancer, inflammation, blood diseases, asthma, skin disease and hypercholesterolemia; biological preparations for the treatment of cancer, inflammation, blood diseases, asthma, skin disease and hypercholesterolemia for medical purposes; hemoglobin; medicines for the treatment of cancer, inflammation, blood diseases, asthma, skin disease and hypercholesterolemia for human purposes; Drugs, namely, pharmaceutical preparations for the treatment of cancer, inflammation, blood diseases, asthma, skin disease and hypercholesterolemia for human purposes; hematogen for the treatment of cancer, inflammation, blood diseases, asthma, skin disease and hypercholesterolemia; injectable medicinal solutions for the treatment of cancer, inflammation, blood diseases, asthma, skin disease and hypercholesterolemia
- Class 035 — Advertising and business services: Retail store services and wholesale store services featuring medicines; Retail store services and wholesale stole services featuring pharmaceutical preparations; Retail store services and wholesale store services featuring sanitary preparations; Retail store services and wholesale store services featuring medical supplies; advertising and publicity services; publicity; organization of exhibitions and events for commercial or advertising purposes; marketing the goods and services of others by providing hyperlinks to websites of others; demonstration of goods; conducting market studies; business appraisals; business investigations; retail store services featuring pharmaceutical, veterinary and sanitary preparations and medical supplies; wholesale store services featuring pharmaceutical, veterinary and sanitary preparations and medical supplies; import-export agency services
- Class 042 — Scientific and technological services: Technological research in the field of medicines and pharmaceutical preparations; research and development of new products for others; scientific laboratory services; product quality testing; conducting technical project studies in the nature of research in the field of pharmaceutical studies; chemical research; chemistry services, namely, research in the field of chemistry; chemical analysis; biological research; bacteriological research; medical and scientific research, namely, conducting clinical trials for others; scientific research
Owner
- Akeso Pharmaceuticals, Inc., Guangzhou, Guangdong, CN
- Akeso Pharmaceuticals, Inc., Guangzhou, Guangdong, CN
- Akeso Pharmaceuticals, Inc., Guangzhou, Guangdong, CN
Prosecution history
- 01 Feb 2024 — TEAS CHANGE OF CORRESPONDENCE RECEIVED
- 01 Feb 2024 — TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
- 01 Feb 2024 — ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
- 01 Feb 2024 — TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
- 23 Jan 2024 — NOTICE OF REGISTRATION CONFIRMATION EMAILED
- 23 Jan 2024 — NOTICE OF REGISTRATION CONFIRMATION EMAILED
- 23 Jan 2024 — REGISTERED-PRINCIPAL REGISTER
- 21 Dec 2023 — 1(B) BASIS DELETED; PROCEED TO REGISTRATION
- 02 Nov 2023 — NOTICE OF ALLOWANCE CANCELLED
- 11 Dec 2023 — CASE ASSIGNED TO INTENT TO USE PARALEGAL
- 04 Nov 2023 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 02 Nov 2023 — SOU EXTENSION 1 GRANTED
- 02 Nov 2023 — SOU EXTENSION 1 FILED
- 02 Nov 2023 — SOU TEAS EXTENSION RECEIVED
- 02 Nov 2023 — TEAS DELETE 1(B) BASIS RECEIVED